Physician profile
Alexandra Kovar
NPI 1942663216
$3,932.53
in general payments reported to CMS, 2019-2025
7 companies · $1,824 in 2025
The $1,824 reported for 2025 was more than what 81% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $76.43 · 2023: $126 · 2024: $1,907 · 2025: $1,824.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,290 · Food and Beverage: $1,066 · Consulting Fee: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,290.42 |
| Food and Beverage | $1,065.68 |
| Consulting Fee | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $2,245.04 | 2024-2025 | Gore Bio-A Tissue Reinforcement, Gore Synecor Preperitoneal Biomaterial |
| Medical Device Business Services, INC. | $695.36 | 2025 | Matrixrib |
| Moon Surgical | $500.00 | 2024 | Maestro System |
| Intuitive Surgical, INC. | $297.15 | 2022-2024 | Da Vinci Surgical System |
| Ethicon INC. | $145.78 | 2024 | Echelon Flex, Stratafix, Evarrest |
| Conmed Corporation | $33.33 | 2022 | |
| Medtronic, INC. | $15.87 | 2025 | Endoflip |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Kovar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.